Treatment of COVID-19: Old Friends for a New Enemy
Pharmaceutical and Biomedical Research
; 6(SpecialIssue1):1-4, 2020.
Article
in English
| EMBASE | ID: covidwho-2323308
antiretroviral therapy; antiviral activity; bioinformatics; Chinese medicine; chronic inflammation; coronavirus disease 2019/dt [Drug Therapy]; COVID-19 pharmacotherapy; economic aspect; Fallopia multiflora; human; Human immunodeficiency virus infection; influenza; letter; Lycoris radiata; malaria; mortality rate; pandemic; Rheum officinale; rheumatoid arthritis; Severe acute respiratory syndrome coronavirus 2; virus load; azithromycin/dt [Drug Therapy]; beta interferon/dt [Drug Therapy]; chloroquine/dt [Drug Therapy]; favipiravir/dt [Drug Therapy]; hydroxychloroquine/dt [Drug Therapy]; lopinavir plus ritonavir/dt [Drug Therapy]; monoclonal antibody/dt [Drug Therapy]; natural product/dt [Drug Therapy]; remdesivir/dt [Drug Therapy]; umifenovir/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Pharmaceutical and Biomedical Research
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS